Indian companies are buying foreign businesses, but BBC thinks it is because of India's 'slow growth'

Indian companies completed more than $18 billion across 162 outbound deals in 2025, a 34% increase year on year, with marquee transactions including Sun Pharma's $11.75 billion Organon deal, Tata Motors' $4.4 billion Iveco acquisition, and Coforge's $2.35 billion Encora purchase. The article is primarily a critique of BBC framing rather than market-moving news, while also citing 7.6% FY2025-26 GDP growth, $81 billion of FDI inflows in 2024-25 (+14% y/y), and ongoing foreign investment by Microsoft, Google, and Apple. Overall tone is mixed-to-neutral for markets, with the main implication being continued strength in Indian corporate balance sheets and outbound M&A activity.

Analysis

The market implication is not the media narrative around “capital flight,” but the balance-sheet signal embedded in outbound deal-making. For OGN, the key issue is that strategic buyers with stronger domestic cash generation can underwrite transformative transactions without needing hostile financing conditions; that raises the probability of a clean close and lowers distress-risk optics around the asset. If the deal is framed as tariff or regulatory arbitrage rather than cyclical weakness, follow-on strategic interest in similar cross-border healthcare assets could re-rate the group as a beneficiary of industrial policy rather than a stranded asset.

MSFT, GOOGL, and AAPL matter here as confirmation of India’s role as a capex destination, not a source of stress. The second-order effect is that large US tech commits reduce the probability of a broad “India slowdown” trade and support medium-term earnings visibility for firms with India exposure in cloud, devices, and services. That should compress the discount investors assign to EM-facing growth names and reduce the odds of a multiple de-rating from macro headlines alone.

The broader contrarian point is that investor attention is likely over-weighting FPI volatility versus FDI durability. If policy stays supportive and domestic credit remains available, outbound M&A should be read as confidence in cash generation, not a capex substitution away from home. The real risk is a delayed reaction: if global rates stay high and domestic consumption softens for several quarters, the market could start to treat these deals as peak-confidence moves rather than disciplined expansion, which would pressure acquirers first through leverage and then through multiple compression.

Key Decisions for Investors

• Long OGN into deal-completion window; use any headline-driven weakness as entry. Base case is downside protection from strategic-buyer demand and valuation support, with 10-15% upside if financing and regulatory risk stay contained.
• Buy MSFT/GOOGL/AAPL on pullbacks tied to India-growth fear headlines over the next 1-3 months. The asymmetry is that these are capex beneficiaries, not macro victims; expect sentiment to recover faster than fundamentals if India FDI remains strong.
• Pair trade: long India-exposed global platform names (MSFT/GOOGL/AAPL basket) vs short a basket of EM-cyclicals sensitive to FPI outflows. This isolates the distinction between sticky FDI and volatile portfolio flows over a 3-6 month horizon.
• For OGN, consider a limited-risk call spread rather than outright stock if you want exposure to a strategic takeout rerate. The setup favors defined downside because the key catalyst is transaction certainty, not operating momentum.
• Avoid shorting Indian corporate exporters on this headline alone; the better expression is to wait for leverage disclosure or integration risk to surface over the next 2-4 quarters before taking the other side.